Journal of Gastroenterology

Article	Citations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	121
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	79
Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae	74
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	70
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	64
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	61
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	57
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	54
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	52
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	49
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	47
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	46
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	41
Reelin level in serum-derived extracellular vesicles predicts regression of M2BPGi-defined liver fibrosis following hepatitis C virus eradication by direct-acting antiviral agents	40
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	39
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	38
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	38
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	38
Regional disparities in pancreaticoduodenectomy mortality: more than just rurality?	38
Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma	35
Single-cell transcriptomics unveils the immunologic landscape of anti-PD-1-associated indirect drug-induced liver injury	33
Clinical practice guidelines for duodenal cancer 2021	32
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	32
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis	32
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	31

Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens	31
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	30
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	30
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	30
Clinicopathological features of localized-type IgG4-related cholecystitis: a nationwide multicenter study in Japan	29
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	29
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	28
Acknowledgements	28
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	28
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study	26
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	25
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	24
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	24
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	24
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	23
Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study	23
Clinical relevance of the identification of the distal end of the palisade vessel in cases with columnar-lined esophagus: a comment on the study by Hatta et al.	23
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	22
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	22
Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis”	22
Clinical significance of gadoxetate sodium-enhanced MRI for detecting liver metastasis in patients with pancreatic cancer: decadal real-world data analysis in Japan	21
Evaluating liver reserve in direct-acting antiviral-treated hepatitis C patients: do we have better surrogate markers?	21
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	21
Is it necessary for endoscopic surveillance for achalasia patients?	20
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	20
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime	20
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia	20
Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease	19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study	19
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma	19
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”	18
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials	18
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases	18
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study	18
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19	18
Targeting autophagy as a therapeutic strategy against pancreatic cancer	18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection	18
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan	17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway	17
Gastric cancer and genomics: review of literature	17
Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan	17
Letter to the editor to ‘‘Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis’’	16
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer	16
Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma	16
An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study	15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society	15
Checking the shape of hepatocellular carcinoma: how irregular is irregular?	15
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 2023	15
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”	15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic	15

Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases	15
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	14
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis	14
Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study	14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation	14
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)	14
HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease	14
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments	14
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?	14
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma	14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions	13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	13
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	13
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease	13
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	13
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	13
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	13
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)	13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	13
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	13
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	13
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	12
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	12
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	12
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study	12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	12
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	11
Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression	11
Renal manifestations in inflammatory bowel disease: a systematic review	11
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data	11
Reply to “Comment on: Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan”	11
Acknowledgements	11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2021	11
Chemotherapy-induced cell cycle arrest is associated with increased claudin-18 isoform 2 expression and enhanced zolbetuximab-mediated cytotoxicity in gastric cancer	10
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	10
Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients	10
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	10
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	10
Comment on “Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan”	10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"	10
The antiferroptotic effect of indigo on ulcerative colitis	10
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	10
Identification of the distal end of the palisade vessels under sedation: a multicenter prospective study in Japan	9
Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9	9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation	9
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy	9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	9
Acknowledgements	9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection	9
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients	9
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	9
Current status of type 1 (IgG4-related) autoimmune pancreatitis	9
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis	9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	9
Differences in adult eosinophilic esophagitis between Japan and Western countries	8
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis	8
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus	8
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease	8
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia	8
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease	8
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion	8
Severity of surgical histopathological fibrosis predicted postoperative recurrence in Crohn’s disease: a multi-center retrospective cohort study	8
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc	8
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer	8
RNF207 promotes colorectal cancer growth by regulating the Hippo–YAP pathway via enhanced MST1 ubiquitination and degradation	8

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	8
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer	8
Reply to “Reappraisal of the MASLD predictive factors: insights beyond the surface”	8
Cost–utility analysis of treatment strategies for chronic constipation in Japan	8
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma	8
Comment on “Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment”: ecological and functional perspectives	8
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis	8
Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	8
Accounting for resumption timing in evaluating the safety of oral anticoagulants following upper gastrointestinal endoscopic submucosal dissection	8
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease	7
Reply to “IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma”	7
Comment on “Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan”: methodological considerations regarding causality, subtyp	7
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression	7
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	7
A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study	7
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	7
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan	7
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	7
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum	7
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases	7
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	7
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study	7
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	7
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review	7
An endoscopic real-time, in situ assessment of intestinal permeability in type 2 diabetes: links to microbiota and hyperglycemia	7
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials	7
METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway	7
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random	7
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis	7
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	7
Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression	7
Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis	7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR	7
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES	7
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	6
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)	6
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients	6
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	6
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	6
Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team	6
Immune checkpoint inhibitor-related pancreatitis: a comprehensive review of epidemiology, pathophysiology, and management	6
Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship	6
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	6
Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?	6
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	6
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	6
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	6
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	6
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	6
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	6
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospec	6
The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma	6
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	6
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	6
Reply to “Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis””	6
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis	5
Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors	5
High-mobility group box 1: friend or foe in pancreatitis	5
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	5
The 2024 diagnostic criteria for primary sclerosing cholangitis	5
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients	5
The clonal heterogeneity of colon cancer with liver metastases	5
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	5
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	5
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	5
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	4
Formation of the pre-metastatic niche by COL9A1 + cancer-associated fibroblasts via SDC4 engagement promotes multi-organ metastasis in gastric cancer	4
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	4
Clinical features and endoscopic polyp management of Peutz–Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan	4
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank	4
Letter to the editor to “Long‑term outcome of PDT for local failure after CRT or RT for oesophageal cancer”	4
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms	4
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	4
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging	4
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	4
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis	4
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI	4
IgG4-related disease in gastroenterology: from pathogenesis to clinical management and long-term outcomes	4
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study	4
Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection	4
A phase I/II clinical trial of neoadjuvant docetaxel/oxaliplatin/S‑1 (DOS) combination therapy for gastroesophageal junction adenocarcinoma	4
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case–control study	4
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	4
Prospective pilot study of functional assessment of the Sphincter of Oddi via cine-dynamic MRCP with selective inversion recovery pulse	4
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments	4
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017	4
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension	4
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan	4
Reply to Letter “Gastric cancer in autoimmune gastritis: ranking the risk” by Prof. Massimo Rugge	4
Future of gastric cancer elimination through Helicobacter pylori eradication therapy in Japan	4
Effect of a histamine-rich meal versus a low-histamine-containing meal on urinary histamine and N-methylhistamine excretion	4